Notably, NSCLC is a cancer for which genotyping of tumor cells, particularly with respect to epidermal growth factor receptor (EGFR) mutations, has demonstrated a remarkable level of success in treatment planning and efficacy (reviewed in [4]). This evidence concerns the gene EGFR and neoplasm.